Literature DB >> 20191376

Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.

Cornelia Schneider1, Ulrich Bothner, Susan S Jick, Christoph R Meier.   

Abstract

Previous large epidemiological studies reporting on the association between chronic obstructive pulmonary disease (COPD) and cardiovascular diseases mainly focussed on prevalent diseases rather than on the incidence of newly diagnosed cardiovascular outcomes. We used the UK-based General Practice Research Database (GPRD) to assess the prevalence and incidence of cardiovascular diseases in COPD patients aged 40-79 between 1995 and 2005, and we randomly matched COPD-free comparison patients to COPD patients. In nested-case control analyses, we compared the risks of developing an incident diagnosis of cardiac arrhythmias, venous thromboembolism, myocardial infarction, or stroke between patients with and without COPD, stratifying the analyses by COPD-severity, using COPD-treatment as proxy for disease severity. We identified 35,772 patients with COPD and the same number of COPD-free patients. Most cardiovascular diseases were more prevalent among COPD patients than among the comparison group of COPD-free patients. The relative risk estimates of developing an incident diagnosis of cardiac arrhythmia (OR 1.19, 95% CI 0.98-1.43), deep vein thrombosis (OR 1.35, 95% CI 0.97-1.89), pulmonary embolism (OR 2.51, 95% CI 1.62-3.87), myocardial infarction (OR 1.40, 95% CI 1.13-1.73), or stroke (OR 1.13, 95% CI 0.92-1.38), tended to be increased for patients with COPD as compared to COPD-free controls. The findings of this large observational study provide further evidence that patients with COPD are at increased risk for most cardiovascular diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20191376     DOI: 10.1007/s10654-010-9435-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

1.  Increased incidence of myocardial infarction and stroke in hypertensive men with reduced lung function.

Authors:  G Engström; B Hedblad; S Valind; L Janzon
Journal:  J Hypertens       Date:  2001-02       Impact factor: 4.844

Review 2.  Antimicrobial-associated QT interval prolongation: pointes of interest.

Authors:  Robert C Owens; Thomas D Nolin
Journal:  Clin Infect Dis       Date:  2006-11-08       Impact factor: 9.079

3.  Chronic obstructive pulmonary disease severity and cardiovascular outcomes.

Authors:  Suellen M Curkendall; Stephan Lanes; Cynthia de Luise; Mary Rose Stang; Judith K Jones; Dewei She; Earl Goehring
Journal:  Eur J Epidemiol       Date:  2006-11-15       Impact factor: 8.082

4.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

5.  Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction.

Authors:  Raymond G Schlienger; Hershel Jick; Christoph R Meier
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

6.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

Review 7.  COPD as a systemic disease.

Authors:  Alvar Agusti; Joan B Soriano
Journal:  COPD       Date:  2008-04       Impact factor: 2.409

8.  Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.

Authors:  A K Johnston; D M Mannino; G W Hagan; K J Davis; V A Kiri
Journal:  Thorax       Date:  2008-02-01       Impact factor: 9.139

9.  The frequency of deep venous thrombosis and pulmonary embolus in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  M Erelel; C Cuhadaroğlu; T Ece; O Arseven
Journal:  Respir Med       Date:  2002-07       Impact factor: 3.415

10.  Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK.

Authors:  Ana Ruigómez; Saga Johansson; Mari-Ann Wallander; Luis Alberto García Rodríguez
Journal:  BMC Cardiovasc Disord       Date:  2005-07-11       Impact factor: 2.298

View more
  50 in total

1.  Combined effect of lung function level and decline increases morbidity and mortality risks.

Authors:  Penelope Baughman; Jacob L Marott; Peter Lange; Christopher J Martin; Anoop Shankar; Edward L Petsonk; Eva Hnizdo
Journal:  Eur J Epidemiol       Date:  2012-12-14       Impact factor: 8.082

2.  Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique.

Authors:  Kirsten van Langevelde; Alexandr Srámek; Patrice W J Vincken; Jan-Kees van Rooden; Frits R Rosendaal; Suzanne C Cannegieter
Journal:  Haematologica       Date:  2012-07-16       Impact factor: 9.941

3.  Phosphodiesterase type 4 blockade prevents platelet-mediated neutrophil recruitment at the site of vascular injury.

Authors:  Licia Totani; Antonio Piccoli; Giuseppe Dell'Elba; Amore Concetta; Angelomaria Di Santo; Nicola Martelli; Lorenzo Federico; Zehra Pamuklar; Susan S Smyth; Virgilio Evangelista
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-12       Impact factor: 8.311

4.  Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario.

Authors:  Murray M Finkelstein; Kenneth R Chapman; R Andrew McIvor; Malcolm R Sears
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

5.  Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.

Authors:  Hilary F Armstrong; Gina S Lovasi; Elsayed Z Soliman; Susan R Heckbert; Bruce M Psaty; John H M Austin; Jerry A Krishnan; Eric A Hoffman; Craig Johnson; Matthew J Budoff; Karol E Watson; R Graham Barr
Journal:  Respir Med       Date:  2016-12-08       Impact factor: 3.415

6.  Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.

Authors:  Martin Söderholm; Malin Inghammar; Bo Hedblad; Arne Egesten; Gunnar Engström
Journal:  Eur J Epidemiol       Date:  2015-12-28       Impact factor: 8.082

7.  Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.

Authors:  Stefania Frasson; Gualberto Gussoni; Pierpaolo Di Micco; Raquel Barba; Laurent Bertoletti; Manuel J Nuñez; Beatriz Valero; Angel Luis Samperiz; Agustina Rivas; Manuel Monreal
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

8.  Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study.

Authors:  David Niederseer; Sabine A M Richter; Daniel Neunhäuserer; Bernd Lamprecht; Sonia A Buist; Michael Studnicka; Josef Niebauer
Journal:  Sleep Breath       Date:  2014-11-27       Impact factor: 2.816

9.  Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period.

Authors:  Tiina Mattila; Tuula Vasankari; Harri Rissanen; Paul Knekt; Pauli Puukka; Markku Heliövaara
Journal:  Eur J Epidemiol       Date:  2017-07-07       Impact factor: 8.082

Review 10.  Early influences on cardiovascular and renal development.

Authors:  J J Miranda Geelhoed; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2010-09-25       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.